Fatty liver disease

Survodutide, Boehringer Ingelheim’s investigational injectable therapy, significantly reduces liver fat and leads to clinically meaningful weight loss in obese or overweight people with metabolic…

YouTube is one of my guiltiest pleasures. I watch everything from cultural and historical videos to food, entertainment, and political channels, especially when the subject…

The Fatty Liver Foundation (FLF) is seeking applicants for a first-of-its-kind program that trains patient advocates to become “equal partners” in shaping research, care,…

Global Fatty Liver Day — being held today, on the second Thursday of June — is shining a spotlight on steatotic liver disease…

Summers in Utah, where I grew up, meant hot days spent boating and swimming in lakes. For my friends and me, they also meant drinking…

I start my day every morning by swallowing a handful of pills with water I keep on my nightstand. It has been this way for…

Treatment with Wegovy (semaglutide) showed a consistent safety and efficacy profile across a range of patient subgroups with metabolic dysfunction-associated steatohepatitis (MASH), a serious…

Today, I sat down to go over my upcoming summer doctor appointments because ’tis the season for my annual upper and lower gastrointestinal scopes and…

Long before I ever set foot inside my gastroenterologist’s office to discuss my liver health and metabolic dysfunction-associated steatohepatitis (MASH), I was diagnosed with…

Belapectin, Galectin Therapeutics’ investigational therapy, significantly reduced the development of new enlarged blood vessels in the esophagus among people with metabolic dysfunction-associated steatohepatitis (MASH),…